WBA
64
4
GLW
42
-3
TAP
60
2
DIS
72
-5
CFG
46
2
CVS
31
2
PNR
66
-3
VTR
43
-3
FCX
50
-2
KEY
31
2
XEL
53
-2
JPM
59
-3
NKE
37
-3
PHM
53
-4
FRT
46
3
PLD
43
-2
AKAM
59
-2
PEP
42
-3
PYPL
62
2
BWA
49
-6
WBA
64
4
GLW
42
-3
TAP
60
2
DIS
72
-5
CFG
46
2
CVS
31
2
PNR
66
-3
VTR
43
-3
FCX
50
-2
KEY
31
2
XEL
53
-2
JPM
59
-3
NKE
37
-3
PHM
53
-4
FRT
46
3
PLD
43
-2
AKAM
59
-2
PEP
42
-3
PYPL
62
2
BWA
49
-6
Financhill
Back

Agape ATP Vs. NovoCure Industry Stock Comparison

Buy
66

ATPC
Agape ATP

Last Price:
1.39
Seasonality Move:
-25.93%
Buy
75

NVCR
NovoCure

Last Price:
33.40
Seasonality Move:
-5.24%
Buy
66
Agape ATP (ATPC) is a Buy

Is Agape ATP a Buy, Sell or Hold?

  • The current Agape ATP [ATPC] share price is $1.43. The Score for ATPC is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • ATPC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ATPC Stock Price Chart

What is Agape ATP's stock price today?

  • The Agape ATP share price today is $1.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATPC is experiencing slight buying pressure.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $33.41
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

ATPC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 41.92 Sell
Chaikin Money Flow: 1528 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.43 - 1.55) Sell
Bollinger Bands (100): (1.46 - 2.18) Sell

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.78 Buy
Relative Strength Index (14 RSI): 75.34 Buy
Chaikin Money Flow: 1118573 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.36 - 28.56) Buy
Bollinger Bands (100): (14.7 - 22.78) Buy

ATPC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.47 Sell
20-day SMA: 1.49 Sell
50-day SMA: 1.58 Sell
200-day SMA: 3.56 Sell
8-day EMA: 1.47 Sell
20-day EMA: 1.5 Sell
50-day EMA: 1.64 Sell
200-day EMA: 12.47 Sell

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.6 Buy
20-day SMA: 23.68 Buy
50-day SMA: 19.33 Buy
200-day SMA: 17.9 Buy
8-day EMA: 29.53 Buy
20-day EMA: 25.45 Buy
50-day EMA: 21.38 Buy
200-day EMA: 19.88 Buy

Agape ATP Earnings Growth & ATPC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.

Agape ATP Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):